Sign in
8-K

Current Report

Keros Therapeutics, Inc. Filed Acc 0001664710-21-000074

Material agreement · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading kros-20211212.htm…